© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2020 MJH Life Sciences™ and Formulary Watch. All rights reserved.
CAPSTONE HEALTH SERVICES FOUNDATION PC
850 5TH AVE E
November 24, 2020
FDA official says the approval is important because of the combination of the flu season and the COVID-19 pandemic.
November 23, 2020
Regeneron's investigational treatment was administered to President Donald Trump in October when he was treated for COVID-19.
November 17, 2020
Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).